文献速递先天性心脏病外科心外重症与机械循环支持

新型汇聚式腔肺连接Fontan中植入轴流机械支持装置的体外研究

In vitro investigation of axial mechanical support devices implanted in the novel convergent cavopulmonary connection Fontan.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

本研究基于12例单心室患者(体表面积0.5-1.75 m²)的心血管磁共振图像构建汇聚式腔肺连接(CCPC)Fontan模型,在体外台架模型中评估Impella RP®与PediPump两种轴流泵的机械循环支持可行性;结果显示装置可对称降低上下腔静脉压力>20 mmHg,并改善所有CCPC模型的肝血流分布平衡。

要点

  • CCPC Fontan设计提供单一流入道与流出道,简化机械循环支持。
  • 两种轴流泵均成功将上下腔静脉压力对称降低>20 mmHg。
  • 装置改善所有CCPC模型的肝血流分布平衡,作者认为需进一步研究。

核心结论

  • CCPC Fontan设计通过平衡肝血流分布和对称降低中心静脉压,为衰竭Fontan提供可行的机械循环支持方案,心指数也可能随支持改善,但作者指出需进一步研究以评估该概念用于管理Fontan衰竭。

研究设计与样本

  • 体外台架模型研究,基于12例单心室患者(体表面积0.5-1.75 m²)的心血管磁共振图像生成三维分割,设计并经计算机优化CCPC模型,对12例全腔肺连接及其对应CCPC模型进行体外台架表征,使用Impella RP®和PediPump两种装置。

主要发现

  • 机械循环支持成功且对称地将上下腔静脉压力降低>20 mmHg。
  • 装置改善所有CCPC模型的肝血流分布平衡(Impella RP® P=0.045,PediPump P=0.055)。
  • 心指数可能随机械循环支持改善。

临床怎么用

  • 作者认为CCPC Fontan设计为衰竭Fontan提供可行的机械循环支持方案,并指出需进一步研究评估该概念用于管理Fontan衰竭。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The 2 opposing inflows and 2 outflows in a total cavopulmonary connection make mechanical circulatory support (MCS) extremely challenging. We have previously reported a novel convergent cavopulmonary connection (CCPC) Fontan design that improves baseline characteristics and provides a single inflow and outflow, thus simplifying MCS. This study aims to assess the feasibility of MCS of this novel configuration using axial flow pumps in an in vitro benchtop model. METHODS: Three-dimensional segmentations of 12 single-ventricle patients (body surface area 0.5-1.75 m2) were generated from cardiovascular magnetic resonance images. The CCPC models were designed by connecting the inferior vena cava and superior vena cava to a shared conduit ascending to the pulmonary arteries, optimized in silico. The 12 total cavopulmonary connection and their corresponding CCPC models underwent in vitro benchtop characterization. Two MCS devices were used, the Impella RP® and the PediPump. RESULTS: MCS successfully and symmetrically reduced the pressure in both vena cavae by >20 mmHg. The devices improved the hepatic flow distribution balance of all CCPC models (Impella RP®P = 0.045, PediPump P = 0.055). CONCLUSIONS: The CCPC Fontan design provides a feasible MCS solution for a failing Fontan by balancing hepatic flow distribution and symmetrically decompressing the central venous pressure. Cardiac index may also improve with MCS. Additional studies are needed to evaluate this concept for managing Fontan failure.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Cleveland V, Contento J, Mass P, et al. In vitro investigation of axial mechanical support devices implanted in the novel convergent cavopulmonary connection Fontan. Eur J Cardiothorac Surg. 2024. PMID: 38180888. doi:10.1093/ejcts/ezad413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。